APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Daridorexant

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Daridorexant Market Outlook and Growth Opportunities 2026

28 December 2025194 pages

Choose your research edition.

Industry ResearchDaridorexant Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Daridorexant Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Daridorexant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daridorexant Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Daridorexant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Daridorexant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Daridorexant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Daridorexant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Daridorexant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Daridorexant market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Daridorexant market include Idorsia. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Daridorexant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Daridorexant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Daridorexant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Daridorexant market size, projected growth trends, production technologies, key applications, and end-use industries.

Daridorexant Segment by Company

Idorsia

Daridorexant Segment by Type

25mg

50mg

Daridorexant Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Daridorexant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Daridorexant status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Daridorexant market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Daridorexant significant trends, drivers, influence factors in global and regions.

6. To analyze Daridorexant competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daridorexant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daridorexant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daridorexant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Daridorexant market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Daridorexant industry.

Chapter 3: Detailed analysis of Daridorexant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Daridorexant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Daridorexant in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Daridorexant Industry Trends Table 2. Daridorexant Industry Drivers Table 3. Daridorexant Industry Opportunities and Challenges Table 4. Daridorexant Industry Restraints Table 5. Global Daridorexant Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Daridorexant Revenue Share by Company (2021-2026) Table 7. Global Daridorexant Sales Volume by Company (k units) & (2021-2026) Table 8. Global Daridorexant Sales Volume Share by Company (2021-2026) Table 9. Global Daridorexant Average Price (USD/unit) of Company (2021-2026) Table 10. Global Daridorexant Company Ranking, (2024-2026) & (USD Million) Table 11. Global Daridorexant Key Company Manufacturing Base & Headquarters Table 12. Global Daridorexant Company, Product Type & Application Table 13. Global Daridorexant Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Daridorexant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 25mg Table 18. Significant Companies of 50mg Table 19. Global Daridorexant Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Daridorexant Sales Volume by Type (2021-2026) & (k units) Table 21. Global Daridorexant Sales Volume by Type (2027-2032) & (k units) Table 22. Global Daridorexant Sales Volume Share by Type (2021-2026) Table 23. Global Daridorexant Sales Volume Share by Type (2027-2032) Table 24. Global Daridorexant Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Daridorexant Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Daridorexant Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Daridorexant Sales Value Share by Type (2021-2026) Table 28. Global Daridorexant Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Daridorexant Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Daridorexant Sales Volume by Application (2021-2026) & (k units) Table 34. Global Daridorexant Sales Volume by Application (2027-2032) & (k units) Table 35. Global Daridorexant Sales Volume Share by Application (2021-2026) Table 36. Global Daridorexant Sales Volume Share by Application (2027-2032) Table 37. Global Daridorexant Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Daridorexant Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Daridorexant Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Daridorexant Sales Value Share by Application (2021-2026) Table 41. Global Daridorexant Sales Value Share by Application (2027-2032) Table 42. Global Daridorexant Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Daridorexant Sales by Region (2021-2026) & (k units) Table 44. Global Daridorexant Sales Market Share by Region (2021-2026) Table 45. Global Daridorexant Sales by Region (2027-2032) & (k units) Table 46. Global Daridorexant Sales Market Share by Region (2027-2032) Table 47. Global Daridorexant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Daridorexant Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Daridorexant Sales Value Share by Region (2021-2026) Table 50. Global Daridorexant Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Daridorexant Sales Value Share by Region (2027-2032) Table 52. Global Daridorexant Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Daridorexant Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Daridorexant Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Daridorexant Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Daridorexant Sales by Country (2021-2026) & (k units) Table 57. Global Daridorexant Sales Market Share by Country (2021-2026) Table 58. Global Daridorexant Sales by Country (2027-2032) & (k units) Table 59. Global Daridorexant Sales Market Share by Country (2027-2032) Table 60. Global Daridorexant Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Daridorexant Sales Value Market Share by Country (2021-2026) Table 62. Global Daridorexant Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Daridorexant Sales Value Market Share by Country (2027-2032) Table 64. Idorsia Company Information Table 65. Idorsia Business Overview Table 66. Idorsia Daridorexant Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Idorsia Daridorexant Product Portfolio Table 68. Idorsia Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Daridorexant Distributors List Table 72. Daridorexant Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Daridorexant Product Image Figure 2. Global Daridorexant Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daridorexant Sales Value (2021-2032) & (US$ Million) Figure 4. Global Daridorexant Sales (2021-2032) & (k units) Figure 5. Global Daridorexant Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Daridorexant Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 25mg Image Figure 10. 50mg Image Figure 11. Global Daridorexant Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Daridorexant Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Daridorexant Sales Volume Share by Type (2021-2032) Figure 14. Global Daridorexant Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Daridorexant Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Daridorexant Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Daridorexant Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Daridorexant Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Daridorexant Sales Volume Share by Application (2021-2032) Figure 23. Global Daridorexant Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Daridorexant Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Daridorexant Sales Value Share by Application (2021-2032) Figure 26. Global Daridorexant Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Daridorexant Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Daridorexant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Daridorexant Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Daridorexant Sales Value (2021-2032) & (US$ Million) Figure 31. North America Daridorexant Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Daridorexant Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Daridorexant Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Daridorexant Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Daridorexant Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Daridorexant Sales Value (2021-2032) & (US$ Million) Figure 37. South America Daridorexant Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Daridorexant Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Daridorexant Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Daridorexant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Daridorexant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Daridorexant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Daridorexant Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Daridorexant Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Idorsia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Daridorexant Sales Value (2021-2032)
  4. 1.2.2 Global Daridorexant Sales Volume (2021-2032)
  5. 1.2.3 Global Daridorexant Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Daridorexant Market Dynamics
  1. 2.1 Daridorexant Industry Trends
  2. 2.2 Daridorexant Industry Drivers
  3. 2.3 Daridorexant Industry Opportunities and Challenges
  4. 2.4 Daridorexant Industry Restraints
3 Daridorexant Market by Company
  1. 3.1 Global Daridorexant Company Revenue Ranking in 2025
  2. 3.2 Global Daridorexant Revenue by Company (2021-2026)
  3. 3.3 Global Daridorexant Sales Volume by Company (2021-2026)
  4. 3.4 Global Daridorexant Average Price by Company (2021-2026)
  5. 3.5 Global Daridorexant Company Ranking (2024-2026)
  6. 3.6 Global Daridorexant Company Manufacturing Base and Headquarters
  7. 3.7 Global Daridorexant Company Product Type and Application
  8. 3.8 Global Daridorexant Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Daridorexant Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Daridorexant Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Daridorexant Market by Type
  1. 4.1 Daridorexant Type Introduction
  2. 4.1.1 25mg
  3. 4.1.2 50mg
  4. 4.2 Global Daridorexant Sales Volume by Type
  5. 4.2.1 Global Daridorexant Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Daridorexant Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Daridorexant Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Daridorexant Sales Value by Type
  9. 4.3.1 Global Daridorexant Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Daridorexant Sales Value by Type (2021-2032)
  11. 4.3.3 Global Daridorexant Sales Value Share by Type (2021-2032)
5 Daridorexant Market by Application
  1. 5.1 Daridorexant Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Daridorexant Sales Volume by Application
  6. 5.2.1 Global Daridorexant Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Daridorexant Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Daridorexant Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Daridorexant Sales Value by Application
  10. 5.3.1 Global Daridorexant Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Daridorexant Sales Value by Application (2021-2032)
  12. 5.3.3 Global Daridorexant Sales Value Share by Application (2021-2032)
6 Daridorexant Regional Sales and Value Analysis
  1. 6.1 Global Daridorexant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Daridorexant Sales by Region (2021-2032)
  3. 6.2.1 Global Daridorexant Sales by Region: 2021-2026
  4. 6.2.2 Global Daridorexant Sales by Region (2027-2032)
  5. 6.3 Global Daridorexant Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Daridorexant Sales Value by Region (2021-2032)
  7. 6.4.1 Global Daridorexant Sales Value by Region: 2021-2026
  8. 6.4.2 Global Daridorexant Sales Value by Region (2027-2032)
  9. 6.5 Global Daridorexant Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Daridorexant Sales Value (2021-2032)
  12. 6.6.2 North America Daridorexant Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Daridorexant Sales Value (2021-2032)
  15. 6.7.2 Europe Daridorexant Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Daridorexant Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Daridorexant Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Daridorexant Sales Value (2021-2032)
  21. 6.9.2 South America Daridorexant Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Daridorexant Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Daridorexant Sales Value Share by Country, 2025 VS 2032
7 Daridorexant Country-level Sales and Value Analysis
  1. 7.1 Global Daridorexant Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Daridorexant Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Daridorexant Sales by Country (2021-2032)
  4. 7.3.1 Global Daridorexant Sales by Country (2021-2026)
  5. 7.3.2 Global Daridorexant Sales by Country (2027-2032)
  6. 7.4 Global Daridorexant Sales Value by Country (2021-2032)
  7. 7.4.1 Global Daridorexant Sales Value by Country (2021-2026)
  8. 7.4.2 Global Daridorexant Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Daridorexant Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Daridorexant Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Daridorexant Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Daridorexant Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Daridorexant Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Daridorexant Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Daridorexant Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Daridorexant Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Daridorexant Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Daridorexant Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Daridorexant Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Daridorexant Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Daridorexant Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Daridorexant Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Daridorexant Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Daridorexant Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Daridorexant Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Daridorexant Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Daridorexant Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Daridorexant Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Daridorexant Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Daridorexant Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Daridorexant Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Daridorexant Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Daridorexant Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Daridorexant Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Daridorexant Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Daridorexant Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Daridorexant Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Daridorexant Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Daridorexant Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Daridorexant Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Daridorexant Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Daridorexant Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Daridorexant Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Daridorexant Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Daridorexant Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Daridorexant Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Daridorexant Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Daridorexant Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Daridorexant Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Daridorexant Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Daridorexant Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Daridorexant Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Daridorexant Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Daridorexant Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Daridorexant Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Daridorexant Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Daridorexant Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Daridorexant Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Daridorexant Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Daridorexant Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Daridorexant Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Daridorexant Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Daridorexant Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Daridorexant Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Daridorexant Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Daridorexant Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Daridorexant Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Daridorexant Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Daridorexant Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Daridorexant Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Daridorexant Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Daridorexant Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Daridorexant Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Daridorexant Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Daridorexant Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Daridorexant Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Daridorexant Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Daridorexant Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Daridorexant Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Daridorexant Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Daridorexant Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Daridorexant Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Daridorexant Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Daridorexant Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Daridorexant Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Daridorexant Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Daridorexant Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Daridorexant Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Daridorexant Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Daridorexant Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Daridorexant Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Daridorexant Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Idorsia
  2. 8.1.1 Idorsia Company Information
  3. 8.1.2 Idorsia Business Overview
  4. 8.1.3 Idorsia Daridorexant Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Idorsia Daridorexant Product Portfolio
  6. 8.1.5 Idorsia Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Daridorexant Value Chain Analysis
  2. 9.1.1 Daridorexant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Daridorexant Sales Mode & Process
  6. 9.2 Daridorexant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Daridorexant Distributors
  9. 9.2.3 Daridorexant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst